CO4940399A1 - Metodo y composicion para el tratamiento de apnea del sueno - Google Patents

Metodo y composicion para el tratamiento de apnea del sueno

Info

Publication number
CO4940399A1
CO4940399A1 CO98018668A CO98018668A CO4940399A1 CO 4940399 A1 CO4940399 A1 CO 4940399A1 CO 98018668 A CO98018668 A CO 98018668A CO 98018668 A CO98018668 A CO 98018668A CO 4940399 A1 CO4940399 A1 CO 4940399A1
Authority
CO
Colombia
Prior art keywords
sleep apnea
treating sleep
inhaler
posterior pharyngeal
pharyngeal region
Prior art date
Application number
CO98018668A
Other languages
English (en)
Inventor
Keith Meyer
Badr Safwan
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of CO4940399A1 publication Critical patent/CO4940399A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Un método para tratar el apnea del sueño comprende:Aplicar una preparación tensoactiva alveolar pulmonaria en una dosis efectiva farmacológicamente para la región faringeal posterior de un paciente antes de un período de sueño. Un método para tratar la apnea del sueño que comprende:Aplicar una preparación tensoactiva que contiene fosfolípido capaz de disminuir la tensión superficial del agua de 15 a 50 mN/m en una dosis efectiva farmacológicamente a la región faringeal posterior de un paciente antes de un período de sueño.Un artículo de manufactura para tratar la apnea del sueño comprende: un vaso inhalador que tiene una porción de reservorio y una porción de boquilla, dicho vaso inhalador siendo capaz de empujar un líquido en forma de aerosol, un líquido contenido en dicho recipiente teniendo la composición de un tensoactivo fosfolípido, y un rótulo fijado a dicho recipiente inhalador, suministrando la dirección de uso en el tratamiento de la apnea de sueñopor medio del cual cuando dicha porción de boquilla se alinea para dirigir dicho aerosol para suministrar un recubrimiento de la región faringeal posterior de un paciente.
CO98018668A 1997-04-16 1998-04-02 Metodo y composicion para el tratamiento de apnea del sueno CO4940399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/834,369 US5958902A (en) 1997-04-16 1997-04-16 Method and composition for treating sleep apnea

Publications (1)

Publication Number Publication Date
CO4940399A1 true CO4940399A1 (es) 2000-07-24

Family

ID=25266775

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98018668A CO4940399A1 (es) 1997-04-16 1998-04-02 Metodo y composicion para el tratamiento de apnea del sueno

Country Status (24)

Country Link
US (3) US5958902A (es)
EP (1) EP1009411B1 (es)
JP (1) JP2001507364A (es)
KR (1) KR100381643B1 (es)
CN (1) CN1252727A (es)
AR (1) AR012221A1 (es)
AT (1) ATE298241T1 (es)
AU (1) AU722866B2 (es)
BG (1) BG103800A (es)
BR (1) BR9809090A (es)
CA (1) CA2285574C (es)
CO (1) CO4940399A1 (es)
DE (1) DE69830660T2 (es)
HK (1) HK1026141A1 (es)
HU (1) HUP0002645A3 (es)
ID (1) ID29298A (es)
IL (2) IL132133A0 (es)
NO (1) NO994613L (es)
NZ (1) NZ337969A (es)
PL (1) PL336326A1 (es)
SK (1) SK143199A3 (es)
TR (1) TR199902577T2 (es)
TW (1) TWI221771B (es)
WO (1) WO1998046245A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6641542B2 (en) * 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
CA2485530A1 (en) * 2002-02-15 2003-08-28 Cns, Inc. Throat spray
WO2003079992A2 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Pulmonary delivery for levodopa
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
WO2007005672A2 (en) * 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
JP2007190278A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
JP2007190277A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器および呼吸訓練プログラム
JP2007190275A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
CA2641821C (en) 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
WO2007147046A2 (en) * 2006-06-14 2007-12-21 Zmed Technologies, Inc. Respiration stimulation
US7734350B2 (en) * 2006-06-14 2010-06-08 Zmed Technologies, Inc. Respiration apparatus
EP2037850A2 (en) 2006-07-06 2009-03-25 Quiescence Medical Inc Apparatus and methods for treating sleep apnea
CA2697822A1 (en) 2007-10-09 2009-04-16 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
EP2534957B1 (en) 2007-12-14 2015-05-27 AeroDesigns, Inc Delivering aerosolizable products
BRPI0920548B8 (pt) 2008-10-09 2021-06-22 Imthera Medical Inc aparelho para controlar posição da língua de um paciente
EP2498868A4 (en) 2009-11-10 2013-05-08 Imthera Medical Inc SYSTEM FOR STIMULATING A HYPOGLOSSAL NERVO FOR CONTROLLING THE TONGUE POSITION IN A PATIENT
WO2012025892A2 (en) * 2010-08-26 2012-03-01 Ben Gurion University Of The Negev Research And Development Authority Apparatus and method for diagnosing obstructive sleep apnea
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US10265013B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
US10265014B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
CN105123928A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种润肠豆渣发酵乳及其制备方法
CN105010535A (zh) * 2015-07-30 2015-11-04 安徽人人福豆业有限公司 一种银耳豆渣发酵乳及其制备方法
CN105104535A (zh) * 2015-07-30 2015-12-02 安徽人人福豆业有限公司 一种养颜豆渣发酵乳及其制备方法
CN105053194A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种清热通络豆渣发酵乳及其制备方法
CN104982527A (zh) * 2015-07-30 2015-10-21 安徽人人福豆业有限公司 一种安神豆渣发酵乳及其制备方法
CN104996566A (zh) * 2015-07-30 2015-10-28 安徽人人福豆业有限公司 一种清肺酒香豆渣发酵乳及其制备方法
CN105053197A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种温中补血豆渣发酵乳及其制备方法
CN105053196A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种风味草莓豆渣发酵乳及其制备方法
CN105123926A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种疏肝理气豆渣发酵乳及其制备方法
CN105053192A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种椰香补肾豆渣发酵乳及其制备方法
CN105123927A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种芦荟健胃豆渣发酵乳及其制备方法
CN105053191A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种消食木瓜豆渣发酵乳及其制备方法
CN105053195A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种去火薄荷味豆渣发酵乳及其制备方法
WO2019018338A1 (en) 2017-07-17 2019-01-24 Northriver Pharm, LLC NASAL COMPOSITION COMPRISING A MUCOADHESIVE POLYMER
CN111568853B (zh) * 2020-04-30 2023-07-28 杭州濡湜生物科技有限公司 一种新型肺部智能释药系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520234A1 (fr) * 1982-01-28 1983-07-29 Gros Pierre Composition destinee a la prevention du ronflement
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
WO1987006943A1 (en) * 1986-05-06 1987-11-19 Children's Hospital Medical Center Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof
JPS63208524A (ja) * 1987-02-25 1988-08-30 Nippon Oil & Fats Co Ltd 睡眠リズム改善剤
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
DE69125750D1 (de) * 1990-05-21 1997-05-28 Abbott Lab Fettsäure-Oberflächenaktives-Lungenprotein Konjate
EP0635028B1 (en) * 1992-04-10 2003-01-22 Abbott Laboratories Pulmonary surfactant protein fragments
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US5925334A (en) * 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance

Also Published As

Publication number Publication date
ID29298A (id) 2001-08-16
KR100381643B1 (ko) 2003-04-26
NZ337969A (en) 2001-12-21
ATE298241T1 (de) 2005-07-15
SK143199A3 (en) 2001-01-18
PL336326A1 (en) 2000-06-19
US6329352B1 (en) 2001-12-11
IL132133A (en) 2008-12-29
TWI221771B (en) 2004-10-11
CA2285574C (en) 2007-11-13
CA2285574A1 (en) 1998-10-22
EP1009411B1 (en) 2005-06-22
EP1009411A1 (en) 2000-06-21
HUP0002645A2 (hu) 2001-06-28
HUP0002645A3 (en) 2002-12-28
WO1998046245A1 (en) 1998-10-22
US5958902A (en) 1999-09-28
AR012221A1 (es) 2000-09-27
AU6975598A (en) 1998-11-11
BG103800A (en) 2000-03-31
CN1252727A (zh) 2000-05-10
NO994613D0 (no) 1999-09-23
TR199902577T2 (xx) 2000-02-21
DE69830660T2 (de) 2006-05-04
NO994613L (no) 1999-10-28
HK1026141A1 (en) 2000-12-08
KR20010006384A (ko) 2001-01-26
EP1009411A4 (en) 2002-10-09
IL132133A0 (en) 2001-03-19
BR9809090A (pt) 2002-12-03
JP2001507364A (ja) 2001-06-05
DE69830660D1 (de) 2005-07-28
US20020099033A1 (en) 2002-07-25
AU722866B2 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
CO4940399A1 (es) Metodo y composicion para el tratamiento de apnea del sueno
AR036854A1 (es) Composicion de sumunistro de agente de beneficio adecuada para suministrarlo a la superficie de un substrato, composicion de suministro de perfume, producto limpiador, composicion limpiadora, y composicion de tratamiento de tela que lo comprenden
DE60044464D1 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
PE98899A1 (es) Un sistema de suministro para una sustancia para el cuidado bucal que utiliza una tira de material que tiene baja rigidez en flexion
DE69923675D1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
DE69921785D1 (de) Nikotininhalator
ATE381926T2 (de) Vitaminzusammenstellung mit verzögerter freigabe
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
ATE348601T1 (de) Im munde zerfallende tablette enthaltend ein benzimidazole
EE05023B1 (et) Fentanli kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette n„htud akuutse valu raviks, ning farmatseutiline kompositsioon
CO5580742A2 (es) Metodos y formas de dosificacion para la administracion con- trolada de paliperidona
DE602004001209D1 (de) Schnell wirkende pharmazeutische zusammensetzung
SE9803239D0 (sv) Composition for the treatment of acute pain
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
AR046811A1 (es) Formas de dosificacion oral de ziprasidona de liberacion sostenida
HK1058902A1 (en) Compositions for protein delivery via the pulmonary route
ES2584183T3 (es) Formulaciones de cladribina para suministro mejorado oral y transmucosa
CO5160329A1 (es) Metodo para proveer absorcion incrementada de una amina far- maceuticamente aceptable en la sangre de un humano y composi cion que comprende una amina farmaceuticamente un farmaco antiinflamatorio no esteroidal
SE0104268L (sv) Andningsbart absorberande alster med konformade hålrum och metod för framställning
CO5820219A1 (es) Un despachador para suministrar espuma y niebla
CO5200840A1 (es) Combinacion de sustancias activas con clonidina
PE28397A1 (es) Soluciones salinas no inorganicas para administracion endonasal
WO2006058017A3 (en) Transmucosal oral delivery device
CO5540323A2 (es) Administracion oral de hormona paratiroides y calcitonina
BR0308038A (pt) Ambroxol para o tratamento de estados doloridos na cavidade bucal e faringe